BackMolecule Holdings Overview

Molecule Holdings Total Current Liabilities

Track Molecule Holdings's total current liabilities ($8.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$8.72M
↑ 50.96% YoYΔ $2.94M vs prior year quarter

Peer trimmed avg / median

Loading

Molecule Holdings Total Current Liabilities History

Loading

Molecule Holdings vs. peers: Total Current Liabilities Comparison

Loading

Molecule Holdings Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecule Holdings (EVRRF) FAQ

Molecule Holdings posts a total current liabilities of $8.7M as of July 2023. That compares with $5.8M in the prior-year period — up 51.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Molecule Holdings's total current liabilities was $5.8M. The latest reading is $8.7M — a 51.0% year-over-year increase (period ending July 2023). Use the history and growth charts on this page for a longer lookback.

Total Current Liabilities is one piece of Molecule Holdings's financial statement story. At $8.7M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for EVRRF's total current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Molecule Holdings's other metric pages and overview cover the third.